Correspondence 0001104659-23-059720 from Addex Therapeutics Ltd. (ADXN) (CIK 0001574232) (ADXN)
Addex Therapeutics Ltd. (ADXN) (CIK 0001574232)
Date: May 12, 2023 · CIK: 0001574232 · Accession: 0001104659-23-059720
AI Filing Summary & Sentiment
File numbers found in text: 333-271611
Letter
United States Securities and Exchange Commission Division of Corporation Finance RE: Addex Therapeutics Ltd Withdrawal of Acceleration Request Registration Statement on Form F-1 File No. 333-271611
Dear Mr. Campbell:
Reference is made to our letter, filed as correspondence via EDGAR on May 11, 2023, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Friday, May 12, 2023, at 4:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
Addex Therapeutics Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Addex Therapeutics
Ltd
Chemin des Mines 9,
CH-1202 Geneva, Switzerland
May 12, 2023
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Alan Campbell
RE: Addex Therapeutics Ltd
Withdrawal
of Acceleration Request
Registration Statement on Form F-1
File No. 333-271611
Dear Mr. Campbell:
Reference is made to our letter, filed as correspondence
via EDGAR on May 11, 2023, in which we requested the acceleration of the effective date of the above-referenced Registration Statement
for Friday, May 12, 2023, at 4:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are
no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request
for acceleration of the effective date.
Very truly yours,
Addex Therapeutics Ltd.
/s/ Tim Dyer
Tim Dyer
Chief Executive Officer
cc: Josh Kaufman, Cooley LLP
Marc Recht, Cooley
LLP
David C. Boles, Cooley (UK) LLP
Frank Gerhard, Homburger AG